Our results highlight a novel mechanism underlying the growth of breast cancer cells and suggest that the EIF4A3-CDC5L axis plays an important role in breast cancer progression and might be a potential therapeutic target for breast cancer. The gene discussed is CDC5L; the disease is breast carcinoma.